Denis Gudkov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Denis Gudkov has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Daiana B. Erdyneeva
Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, Moscow, Russia
2 shared publications - Daria A. Chudakova
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia
2 shared publications - Elena V. Petersen
Institute of Future Biophysics, Institutsky Lane, 9, Dolgoprudny 141700, Moscow Region, Russia
2 shared publications - Evgeniya Shabalina
Институт биофизики будущего, пер. Институтский, 9, Долгопрудный, Московская область, 141701, Российская Федерация
2 shared publications - Igor Vladimirovich Reshetov
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
2 shared publications - Olga Nikolaevna Tkacheva
Russian Gerontology Clinical Research Center of Pirogov Russian National Research Medical University
2 shared publications
Latest Publications
- Open Access
- 9 November 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 10044
Integrated microRNA and mRNA Profiling in the Corneal Endothelium of Fuchs Endothelial Corneal Dystrophy
MicroRNAs (miRNAs) are endogenous non-coding RNAs that post-transcriptionally modulate gene expression, playing roles in both development and disease pathogenesis. This study specifically investigates the differential miRNA expression in human FECD endothelium compared to healthy controls. By integrating this miRNAome profile with our existing transcriptomic background, we aimed to identify candidate miRNA–target gene regulatory relationships potentially relevant to FECD. NanoString nCounter miRNA profiling was performed on corneal endothelium from FECD patients and controls. Differential expression analysis was conducted, followed by correlation of miRNAs with transcriptomic data from matched samples. Functional enrichment was performed for negatively correlated miRNA–mRNA pairs to identify pathways relevant to FECD pathogenesis. We found 98 differentially expressed miRNAs between FECD and controls. Correlation analysis revealed negatively correlated candidate miRNA–target gene pairs, highlighting potential regulatory interactions. Enrichment analysis of target genes implicated PI3K-AKT, TNF, AGE-RAGE, and focal adhesion pathways as part of FECD molecular alterations. Several dysregulated miRNAs (e.g., miR-302 and miR-630) were associated with processes such as extracellular matrix remodeling, apoptosis, and inflammatory signaling, consistent with key pathogenic features of FECD. This exploratory study provides new insights into the pathogenesis of FECD by integrating miRNA profiling with a transcriptomic background. This combined analysis highlights candidate miRNA–target associations identified within the FECD group and places them into potentially regulatory pathways relevant to endothelial degeneration. The observed miR-29 expression trends are hypothesis-generating; however, the miR-29 family did not meet the prespecified FDR threshold and was not retained in the final correlation network, precluding confirmation of its contribution to ECM remodeling in our cohort. In parallel, comparison with earlier array-based studies revealed inconsistencies that may partly reflect differences in platforms and cohorts; these discrepancies warrant further investigation in independent cohorts. Finally, the analysis of mirtronic host genes uncovered unstable correlations, suggesting that array-based measurements alone are insufficient for reliable miRNA quantification. Together, these findings refine our understanding of FECD-related networks, resolve some earlier contradictions, and open directions for more robust validation and therapeutic exploration.
- 9 November 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 10044
Open AccessIntegrated microRNA and mRNA Profiling in the Corneal Endothelium of Fuchs Endothelial Corneal Dystrophy
MicroRNAs (miRNAs) are endogenous non-coding RNAs that post-transcriptionally modulate gene expression, playing roles in both development and disease pathogenesis. This study specifically investigates the differential miRNA expression in human FECD endothelium compared to healthy controls. By integrating this miRNAome profile with our existing transcriptomic background, we aimed to identify candidate miRNA–target gene regulatory relationships potentially relevant to FECD. NanoString nCounter miRNA profiling was performed on corneal endothelium from FECD patients and controls. Differential expression analysis was conducted, followed by correlation of miRNAs with transcriptomic data from matched samples. Functional enrichment was performed for negatively correlated miRNA–mRNA pairs to identify pathways relevant to FECD pathogenesis. We found 98 differentially expressed miRNAs between FECD and controls. Correlation analysis revealed negatively correlated candidate miRNA–target gene pairs, highlighting potential regulatory interactions. Enrichment analysis of target genes implicated PI3K-AKT, TNF, AGE-RAGE, and focal adhesion pathways as part of FECD molecular alterations. Several dysregulated miRNAs (e.g., miR-302 and miR-630) were associated with processes such as extracellular matrix remodeling, apoptosis, and inflammatory signaling, consistent with key pathogenic features of FECD. This exploratory study provides new insights into the pathogenesis of FECD by integrating miRNA profiling with a transcriptomic background. This combined analysis highlights candidate miRNA–target associations identified within the FECD group and places them into potentially regulatory pathways relevant to endothelial degeneration. The observed miR-29 expression trends are hypothesis-generating; however, the miR-29 family did not meet the prespecified FDR threshold and was not retained in the final correlation network, precluding confirmation of its contribution to ECM remodeling in our cohort. In parallel, comparison with earlier array-based studies revealed inconsistencies that may partly reflect differences in platforms and cohorts; these discrepancies warrant further investigation in independent cohorts. Finally, the analysis of mirtronic host genes uncovered unstable correlations, suggesting that array-based measurements alone are insufficient for reliable miRNA quantification. Together, these findings refine our understanding of FECD-related networks, resolve some earlier contradictions, and open directions for more robust validation and therapeutic exploration.
- 3 November 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (10)
Genetic markers of stress susceptibility: From individual risk — to the differential sensitivity hypothesis. (Systematic review)
Objective. To summarize current findings on genetic markers and multigenic panels associated with stress susceptibility, explore their roles within the differential susceptibility hypothesis, and evaluate the potential for genetic testing in psychosomatic practice. Material and methods. A systematic analysis was conducted of publications from international and Russian databases (PubMed, Scopus, eLIBRARY) spanning 2000 to 2025, focusing on the genetic aspects of stress resistance and the risk of psychosomatic disorders. Results. The analysis included key candidate genes and genetic variants that regulate the stress response, including SLC6A4/5-HTTLPR, BDNF rs6265, COMT rs4680, FKBP5 rs1360780, DRD4 48-bp VNTR, OXTR rs53576/rs2254298, etc. The review discusses their associations with variability in stress response, emotional regulation, and the risk of stress-related mental and psychosomatic disorders. The findings support the concept of differential susceptibility, suggesting that «plastic» genotypes can increase vulnerability in adverse environments while simultaneously enhancing adaptability when social and psychological support is present. Thus, the development of multigenic panels to assess individual risk emerges as a promising avenue. Conclusion. Recognizing genetic predisposition to stress introduces opportunities for personalized prevention and treatment of psychosomatic disorders. Advancing multigenic panels will enhance the effectiveness of risk stratification and facilitate the selection of tailored interventions.
- 3 November 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (10)
Genetic markers of stress susceptibility: From individual risk — to the differential sensitivity hypothesis. (Systematic review)
Objective. To summarize current findings on genetic markers and multigenic panels associated with stress susceptibility, explore their roles within the differential susceptibility hypothesis, and evaluate the potential for genetic testing in psychosomatic practice. Material and methods. A systematic analysis was conducted of publications from international and Russian databases (PubMed, Scopus, eLIBRARY) spanning 2000 to 2025, focusing on the genetic aspects of stress resistance and the risk of psychosomatic disorders. Results. The analysis included key candidate genes and genetic variants that regulate the stress response, including SLC6A4/5-HTTLPR, BDNF rs6265, COMT rs4680, FKBP5 rs1360780, DRD4 48-bp VNTR, OXTR rs53576/rs2254298, etc. The review discusses their associations with variability in stress response, emotional regulation, and the risk of stress-related mental and psychosomatic disorders. The findings support the concept of differential susceptibility, suggesting that «plastic» genotypes can increase vulnerability in adverse environments while simultaneously enhancing adaptability when social and psychological support is present. Thus, the development of multigenic panels to assess individual risk emerges as a promising avenue. Conclusion. Recognizing genetic predisposition to stress introduces opportunities for personalized prevention and treatment of psychosomatic disorders. Advancing multigenic panels will enhance the effectiveness of risk stratification and facilitate the selection of tailored interventions.
- Open Access
- 18 December 2025
- Published by MDPI AG in Metabolites
- Vol. 15 (12) , 803
Metabolomic Profiling of Long-Lived Individuals Reveals a Distinct Subgroup with Cardiovascular Disease and Elevated Butyric Acid Derivatives
Background/Objectives : Understanding metabolic adaptations in long-livers provides critical insights into the biochemical mechanisms underlying extreme longevity. While many long-livers maintain metabolic stability, others exhibit significant metabolic alterations, potentially linked to age-related diseases. This study aims to identify distinct metabolic signatures in long-livers and their associations with clinical outcomes, particularly cardiovascular disease. Methods: We analyzed serum samples from 53 oldest long-livers (mean age 98.2 ± 2 years) using liquid chromatography–tandem mass spectrometry (LC-MS/MS) to identify metabolic alterations and gathered clinical data to link the detected metabolic changes with phenotypes. Results: Using Welch’s t-test with Benjamini–Hochberg FDR correction (q < 0.01, |log2FC| > 2), we identified 15 significantly altered metabolites distinguishing a subgroup of 6 long-livers from 47 metabolically stable individuals. This metabolically altered subgroup exhibited striking elevations in key metabolites, including L-serine (log2FC = 8.05, >250-fold increase, q = 1.26 × 10−8), D-galactose (log2FC = 6.86, 116-fold, q = 8.87 × 10−7), butyric acid (log2FC = 6.24, 75-fold, q = 9.79 × 10−5), and choline (log2FC = 6.11, ~69-fold, q = 5.45 × 10−7), with enrichment in the butyric acid metabolism pathway. Post hoc power analysis confirmed >80% power for all significant metabolites with very large effect sizes (Cohen’s d > 2.0). Conclusions: Our findings reveal substantial metabolic heterogeneity among long-livers, with a distinct subgroup exhibiting profound metabolic alterations and clinical features associated with cardiovascular and systemic disease. These results highlight that the butyric acid pathway may contribute to age-related disease survival in extreme aging.
- 18 December 2025
- Published by MDPI AG in Metabolites
- Vol. 15 (12) , 803
Open AccessMetabolomic Profiling of Long-Lived Individuals Reveals a Distinct Subgroup with Cardiovascular Disease and Elevated Butyric Acid Derivatives
Background/Objectives : Understanding metabolic adaptations in long-livers provides critical insights into the biochemical mechanisms underlying extreme longevity. While many long-livers maintain metabolic stability, others exhibit significant metabolic alterations, potentially linked to age-related diseases. This study aims to identify distinct metabolic signatures in long-livers and their associations with clinical outcomes, particularly cardiovascular disease. Methods: We analyzed serum samples from 53 oldest long-livers (mean age 98.2 ± 2 years) using liquid chromatography–tandem mass spectrometry (LC-MS/MS) to identify metabolic alterations and gathered clinical data to link the detected metabolic changes with phenotypes. Results: Using Welch’s t-test with Benjamini–Hochberg FDR correction (q < 0.01, |log2FC| > 2), we identified 15 significantly altered metabolites distinguishing a subgroup of 6 long-livers from 47 metabolically stable individuals. This metabolically altered subgroup exhibited striking elevations in key metabolites, including L-serine (log2FC = 8.05, >250-fold increase, q = 1.26 × 10−8), D-galactose (log2FC = 6.86, 116-fold, q = 8.87 × 10−7), butyric acid (log2FC = 6.24, 75-fold, q = 9.79 × 10−5), and choline (log2FC = 6.11, ~69-fold, q = 5.45 × 10−7), with enrichment in the butyric acid metabolism pathway. Post hoc power analysis confirmed >80% power for all significant metabolites with very large effect sizes (Cohen’s d > 2.0). Conclusions: Our findings reveal substantial metabolic heterogeneity among long-livers, with a distinct subgroup exhibiting profound metabolic alterations and clinical features associated with cardiovascular and systemic disease. These results highlight that the butyric acid pathway may contribute to age-related disease survival in extreme aging.
- Open Access
- 28 June 2023
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 22 (3) , 108-118-118
Non-invasive methods of molecular diagnosis, clinical monitoring and approaches to the personalized therapy of diffuse midline glioma
The purpose of the study was to summarize and analyze modern data about non-invasive methods of molecular diagnosis and approaches to the personalized therapy of diffuse midline glioma (DMG). Material and Methods. The search and analysis of publications was carried out using Google Scholar, Pubmed, Elsevier, Web of Science, Elibrary systems. The review includes publications published from 2011 to 2022. Of the 102 articles found, 59 were used to write the review. Results. In this review, we discuss the spectrum of somatic driver mutations present in DMG tumor cells and their relationship with the sensitivity of tumor cells to certain types of therapy - a pharmacogenetic approach to the selection of individual treatments (targeted therapy). We provide examples of new methods of targeted therapy for DMG, which are currently at the stage of preclinical laboratory development. Also, we discuss examples of the use of 3D cell cultures for the development of targeted therapies, including the use of perfusion systems. The review describes the methods of analysis of liquid biopsy, which allow the detection of tumor-specific biomarkers in the non-invasive diagnosis of DMG, including a number of methods that have not yet been tested in the clinic. The following is a list of tumor-specific biomarkers for diagnosing, monitoring, and selecting targeted therapy for DMG. Finally, we discuss the possibility of implementing these methods in the clinic and present the results of several clinical trials. Conclusion. In oncology, new methods of molecular genetics, such as analysis of liquid biopsy, allow diagnosis and monitoring of treatment in cases where classical methods that require tissue sampling are not applicable (for example, the analysis of genetically heterogeneous tumors and tumors of surgically inaccessible localization). These tumors include DMG, a primary brain tumor most common in children. The available data confirm the relevance of the search for new specific tumor biomarkers, as well as targets for targeted therapy of the paediatric-type diffuse gliomas.
- 28 June 2023
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 22 (3) , 108-118-118
Open AccessNon-invasive methods of molecular diagnosis, clinical monitoring and approaches to the personalized therapy of diffuse midline glioma
The purpose of the study was to summarize and analyze modern data about non-invasive methods of molecular diagnosis and approaches to the personalized therapy of diffuse midline glioma (DMG). Material and Methods. The search and analysis of publications was carried out using Google Scholar, Pubmed, Elsevier, Web of Science, Elibrary systems. The review includes publications published from 2011 to 2022. Of the 102 articles found, 59 were used to write the review. Results. In this review, we discuss the spectrum of somatic driver mutations present in DMG tumor cells and their relationship with the sensitivity of tumor cells to certain types of therapy - a pharmacogenetic approach to the selection of individual treatments (targeted therapy). We provide examples of new methods of targeted therapy for DMG, which are currently at the stage of preclinical laboratory development. Also, we discuss examples of the use of 3D cell cultures for the development of targeted therapies, including the use of perfusion systems. The review describes the methods of analysis of liquid biopsy, which allow the detection of tumor-specific biomarkers in the non-invasive diagnosis of DMG, including a number of methods that have not yet been tested in the clinic. The following is a list of tumor-specific biomarkers for diagnosing, monitoring, and selecting targeted therapy for DMG. Finally, we discuss the possibility of implementing these methods in the clinic and present the results of several clinical trials. Conclusion. In oncology, new methods of molecular genetics, such as analysis of liquid biopsy, allow diagnosis and monitoring of treatment in cases where classical methods that require tissue sampling are not applicable (for example, the analysis of genetically heterogeneous tumors and tumors of surgically inaccessible localization). These tumors include DMG, a primary brain tumor most common in children. The available data confirm the relevance of the search for new specific tumor biomarkers, as well as targets for targeted therapy of the paediatric-type diffuse gliomas.
- Open Access
- 11 May 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (10) , 8579
COVID-19—The Shift of Homeostasis into Oncopathology or Chronic Fibrosis in Terms of Female Reproductive System Involvement
The COVID-19 pandemic caused by the SARS-CoV-2 coronavirus remains a global public health concern due to the systemic nature of the infection and its long-term consequences, many of which remain to be elucidated. SARS-CoV-2 targets endothelial cells and blood vessels, altering the tissue microenvironment, its secretion, immune-cell subpopulations, the extracellular matrix, and the molecular composition and mechanical properties. The female reproductive system has high regenerative potential, but can accumulate damage, including due to SARS-CoV-2. COVID-19 is profibrotic and can change the tissue microenvironment toward an oncogenic niche. This makes COVID-19 and its consequences one of the potential regulators of a homeostasis shift toward oncopathology and fibrosis in the tissues of the female reproductive system. We are looking at SARS-CoV-2-induced changes at all levels in the female reproductive system.
- 11 May 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (10) , 8579
Open AccessCOVID-19—The Shift of Homeostasis into Oncopathology or Chronic Fibrosis in Terms of Female Reproductive System Involvement
The COVID-19 pandemic caused by the SARS-CoV-2 coronavirus remains a global public health concern due to the systemic nature of the infection and its long-term consequences, many of which remain to be elucidated. SARS-CoV-2 targets endothelial cells and blood vessels, altering the tissue microenvironment, its secretion, immune-cell subpopulations, the extracellular matrix, and the molecular composition and mechanical properties. The female reproductive system has high regenerative potential, but can accumulate damage, including due to SARS-CoV-2. COVID-19 is profibrotic and can change the tissue microenvironment toward an oncogenic niche. This makes COVID-19 and its consequences one of the potential regulators of a homeostasis shift toward oncopathology and fibrosis in the tissues of the female reproductive system. We are looking at SARS-CoV-2-induced changes at all levels in the female reproductive system.
- Open Access
- 30 July 2020
- Published by MDPI AG in Microorganisms
- Vol. 8 (8) , 1162
A Cross-Sectional Study of the Gut Microbiota Composition in Moscow Long-Livers
The aim was to assess the gut microbiota of long-livers from Moscow. This study included two groups of patients who signed their consent to participate. The group of long-livers (LL) included 20 participants aged 97–100 years (4 men and 16 women). The second group included 22 participants aged 60–76 years (6 men) without clinical manifestations of chronic diseases (healthy elderly). Gut microbiota was studied by 16S rRNA sequencing. Long-livers underwent a complex geriatric assessment as well as expanded blood biochemistry. Gut microbiota composition in the cohorts was also compared with microbiome in long-livers from Japan and Italy. Russian long-livers’ microbiome contained more beneficial bacteria than healthy elderly including Ruminococcaceae, Christensenellaceae, Lactobacillaceae families. Conditional pathogens like Veillonellaceae, Mogibacteriaceae, Alcaligenaceae, Peptococcaceae, Peptostreptococcaceae were more abundant in the healthy elderly. Compared with Italian and Japanese microbiome LL, the Russian LL appeared to be more similar to the Italian cohort. Bifidobacterium/Coprococcus and Faecalibacterium/Coprococcus balances were associated with femoral and carotid intima–media thickness, respectively. Bifidobacterium/Coriobacteriaceae balance was assessed with the folic acid level and Faecalibacterium/Coriobacteriaceae_u the with Mini Nutritional Assessment score. Long-livers’ microbiome appeared to be unexpectedly balanced. The high representation of beneficial bacteria in long-livers may prevent them from low-grade inflammation and thus protect them from the development of atherosclerosis and other aging-associated conditions.
- 30 July 2020
- Published by MDPI AG in Microorganisms
- Vol. 8 (8) , 1162
Open AccessA Cross-Sectional Study of the Gut Microbiota Composition in Moscow Long-Livers
The aim was to assess the gut microbiota of long-livers from Moscow. This study included two groups of patients who signed their consent to participate. The group of long-livers (LL) included 20 participants aged 97–100 years (4 men and 16 women). The second group included 22 participants aged 60–76 years (6 men) without clinical manifestations of chronic diseases (healthy elderly). Gut microbiota was studied by 16S rRNA sequencing. Long-livers underwent a complex geriatric assessment as well as expanded blood biochemistry. Gut microbiota composition in the cohorts was also compared with microbiome in long-livers from Japan and Italy. Russian long-livers’ microbiome contained more beneficial bacteria than healthy elderly including Ruminococcaceae, Christensenellaceae, Lactobacillaceae families. Conditional pathogens like Veillonellaceae, Mogibacteriaceae, Alcaligenaceae, Peptococcaceae, Peptostreptococcaceae were more abundant in the healthy elderly. Compared with Italian and Japanese microbiome LL, the Russian LL appeared to be more similar to the Italian cohort. Bifidobacterium/Coprococcus and Faecalibacterium/Coprococcus balances were associated with femoral and carotid intima–media thickness, respectively. Bifidobacterium/Coriobacteriaceae balance was assessed with the folic acid level and Faecalibacterium/Coriobacteriaceae_u the with Mini Nutritional Assessment score. Long-livers’ microbiome appeared to be unexpectedly balanced. The high representation of beneficial bacteria in long-livers may prevent them from low-grade inflammation and thus protect them from the development of atherosclerosis and other aging-associated conditions.